Works matching IS 2160763X AND DT 2015 AND VI 4 AND IP 6

Results: 12

Evaluation of opicapone on cardiac repolarization in a thorough QT/QTc study.

Published in:

Clinical Pharmacology in Drug Development, 2015, v. 4, n. 6, p. 454, doi. 10.1002/cpdd.188

By:

Pinto, Roberto;
l'Hostis, Philippe;
Patat, Alain;
Homery, Marie‐Claude;
Falcão, Amílcar;
Nunes, Teresa;
Rocha, José‐Francisco;
Soares‐da‐Silva, Patrício

Publication type:

Article

Effect of lapatinib on oral digoxin absorption in patients.

Published in:

Clinical Pharmacology in Drug Development, 2015, v. 4, n. 6, p. 449, doi. 10.1002/cpdd.189

By:

Koch, Kevin M.;
Smith, Deborah A.;
Botbyl, Jeff;
Arya, Nikita;
Briley, Linda P.;
Cartee, Leanne;
White, Jane Holshouser;
Beyer, Jennifer;
Dar, Mohammed M.;
Chung, Hyun Choel;
Chu, Quincy;
Bang, Yung‐Jue

Publication type:

Article

Pharmacokinetic drug-drug interaction assessment between LCZ696, an angiotensin receptor neprilysin inhibitor, and hydrochlorothiazide, amlodipine, or carvedilol.

Published in:

Clinical Pharmacology in Drug Development, 2015, v. 4, n. 6, p. 407, doi. 10.1002/cpdd.183

By:

Hsiao, Hsiu‐ling;
Langenickel, Thomas Heiko;
Greeley, Michael;
Roberts, John;
Zhou, Wei;
Pal, Parasar;
Rebello, Sam;
Rajman, Iris;
Sunkara, Gangadhar

Publication type:

Article

Oral tramadol pharmacokinetics in pediatric subjects versus adults-Is there a role of delayed gastric emptying in pediatric subjects?

Published in:

Clinical Pharmacology in Drug Development, 2015, v. 4, n. 6, p. 473, doi. 10.1002/cpdd.230

By:

Srinivas, Nuggehally R.

Publication type:

Article

Safety, tolerability, and pharmacokinetics of multiple ascending doses of naloxegol.

Published in:

Clinical Pharmacology in Drug Development, 2015, v. 4, n. 6, p. 442, doi. 10.1002/cpdd.204

By:

Eldon, Michael A.;
Kugler, Alan R.;
Medve, Robert A.;
Bui, Khanh;
Butler, Kathleen;
Sostek, Mark

Publication type:

Article

Issue Information.

Published in:: Clinical Pharmacology in Drug Development, 2015, v. 4, n. 6, p. i, doi. 10.1002/cpdd.158
Publication type:: Article

Population pharmacokinetic modeling of motesanib and its active metabolite, M4, in cancer patients.

Published in:

Clinical Pharmacology in Drug Development, 2015, v. 4, n. 6, p. 463, doi. 10.1002/cpdd.196

By:

Gosselin, Nathalie H.;
Mouksassi, Mohamad‐Samer;
Lu, Jian‐Feng;
Hsu, Cheng‐Pang

Publication type:

Article

Effect of tamsulosin on the pharmacokinetics of dutasteride in Chinese male healthy volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2015, v. 4, n. 6, p. 427, doi. 10.1002/cpdd.197

By:

Li, Huafang;
Yang, Jiansong;
Zhao, Hongxin;
Fossler, Michael J.;
Wang, Chunrong

Publication type:

Article

A single- and multiple-dose study to investigate the pharmacokinetics of epelsiban and its metabolite, GSK2395448, in healthy female volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2015, v. 4, n. 6, p. 418, doi. 10.1002/cpdd.210

By:

Mahar, Kelly M.;
Stier, Brendt;
Fries, Michael;
McCallum, Stewart W.

Publication type:

Article

Safety, tolerability, pharmacokinetics, and pharmacodynamic effects of naloxegol at peripheral and central nervous system receptors in healthy male subjects: A single ascending-dose study.

Published in:

Clinical Pharmacology in Drug Development, 2015, v. 4, n. 6, p. 434, doi. 10.1002/cpdd.206

By:

Eldon, Michael A.;
Kugler, Alan R.;
Medve, Robert A.;
Bui, Khanh;
Butler, Kathleen;
Sostek, Mark

Publication type:

Article

Authors' response to the letter from Dr. Srinivas.

Published in:

Clinical Pharmacology in Drug Development, 2015, v. 4, n. 6, p. 475, doi. 10.1002/cpdd.231

By:

Vandenbossche, J.;
Richards, H.;
Solanki, B.;
Van Peer, A.

Publication type:

Article

The expanding utility of microdosing.

Published in:

Clinical Pharmacology in Drug Development, 2015, v. 4, n. 6, p. 401, doi. 10.1002/cpdd.235

By:

Lappin, Graham

Publication type:

Article